Certified Clinical Research Coordinator (CCRC®) Exam 2026
Latest Comprehensive Study Guide with Practice Questions Clinical
Trial Coordination Review — Detailed Rationales, Verified
Answers, Success Workbook
SECTION 1: Clinical Trial Operations / GCPs (23% of Exam)
Question 1
According to ICH E6(R3) Good Clinical Practice, what is the PRIMARY purpose
of GCP?
A) To reduce the cost of clinical research for sponsors
B) To provide assurance that the data and reported results are credible and
accurate and that the rights, safety, and well-being of trial subjects are
protected
C) To accelerate the drug approval process
D) To ensure pharmaceutical companies maximize their return on investment
Rationale: ICH GCP provides an international ethical and scientific quality
standard for designing, conducting, recording, and reporting trials involving human
subjects. Its primary purpose is to provide assurance that data and reported
results are credible and accurate, and that the rights, safety, and well-being of
trial subjects are protected. This fundamental principle remains unchanged in
E6(R3).
Question 2
A clinical research coordinator discovers that a subject missed two study visits.
What is this considered?
A) Adverse event
B) Protocol deviation
C) Serious noncompliance
D) Data discrepancy
Rationale: A missed scheduled study visit is considered a protocol deviation — a
change, divergence, or departure from the IRB-approved protocol. All protocol
,deviations should be documented, reported to the IRB per site policy, and
discussed with the Principal Investigator.
Question 3
What is the timeframe for submitting an IND Safety Report to the FDA for a fatal
or life-threatening unexpected suspected adverse reaction?
A) 24 hours
B) 7 calendar days
C) 15 calendar days
D) 30 calendar days
Rationale: Under 21 CFR 312.32, IND Safety Reports for fatal or life-
threatening unexpected suspected adverse reactions must be submitted to the
FDA within 7 calendar days. Other serious unexpected suspected adverse
reactions must be submitted within 15 calendar days. This timeframe is consistent
across clinical research regulations.
Question 4
Which of the following is an example of source documentation in a clinical trial?
A) The Case Report Form (CRF)
B) The subject's original medical record
C) The statistical analysis plan
D) The study protocol
Rationale: Source documentation consists of original records and certified copies
of clinical findings, observations, or other activities. Source documents
include medical records, laboratory reports, participant diaries, and other original
records where data are first recorded. The CRF is where data from source
documents are transcribed, not the source itself.
Question 5
What is the investigator's responsibility regarding investigational product
accountability?
,A) To ensure that the product is stored in the investigator's office
B) To maintain accurate records of the receipt, dispensing, and return of the
investigational product
C) To allow anyone to dispense the product without documentation
D) To destroy unused product without any recordkeeping
Rationale: The investigator is responsible for maintaining accurate records of
the receipt, dispensing, and return of the investigational product. This ensures
accountability and allows reconciliation of the product at the end of the study.
Question 6
What is the purpose of monitoring in a clinical trial?
A) To ensure the sponsor is making a profit
B) To verify that the rights and well-being of human subjects are protected,
that the reported data are accurate and complete, and that the conduct of the
trial is in compliance with the protocol, GCP, and applicable regulations
C) To ensure that the study is completed on time
D) To check the investigator's credentials only
Rationale: The purpose of monitoring is to verify that the rights and well-being of
human subjects are protected, that the reported data are accurate and complete, and
that the conduct of the trial is in compliance with the protocol, GCP, and
applicable regulations. Monitoring is a critical GCP requirement.
Question 7
What is the purpose of a Case Report Form (CRF)?
A) To record adverse events only
B) To collect and record data for each trial participant in a standardized
format
C) To obtain informed consent
D) To document the study protocol only
Rationale: A Case Report Form (CRF) is a document used to collect and record
data for each trial participant in a standardized format. It ensures that data are
collected consistently across all sites and participants, enabling accurate analysis.
, Question 8
What is the difference between a protocol deviation and a protocol violation?
A) There is no difference; they are the same
B) A protocol deviation is a minor departure from the protocol; a protocol
violation is a significant departure that may affect participant safety or data
integrity
C) A protocol deviation is intentional; a protocol violation is unintentional
D) A protocol deviation is reported to the FDA; a protocol violation is not
Rationale: A protocol deviation is generally a minor departure from the protocol
that does not significantly affect participant safety or data integrity. A protocol
violation is a significant departure that may affect participant safety, rights, or
welfare, or the integrity of the study data. Violations require more urgent reporting
and corrective action.
Question 9
What is the purpose of a query in clinical data management?
A) To ask the participant a question about their health
B) To request clarification or correction of data that appears to be missing,
inconsistent, or erroneous
C) To change the protocol mid-study
D) To terminate a participant from the study
Rationale: A query is a request for clarification or correction of data that appears
to be missing, inconsistent, or erroneous. Queries are typically generated by data
management or monitors and must be resolved before the database is locked.
Question 10
What is the purpose of the Investigator's Brochure (IB)?
A) A document that lists all study personnel
B) A comprehensive document containing the clinical and non-clinical data on
the investigational product
Latest Comprehensive Study Guide with Practice Questions Clinical
Trial Coordination Review — Detailed Rationales, Verified
Answers, Success Workbook
SECTION 1: Clinical Trial Operations / GCPs (23% of Exam)
Question 1
According to ICH E6(R3) Good Clinical Practice, what is the PRIMARY purpose
of GCP?
A) To reduce the cost of clinical research for sponsors
B) To provide assurance that the data and reported results are credible and
accurate and that the rights, safety, and well-being of trial subjects are
protected
C) To accelerate the drug approval process
D) To ensure pharmaceutical companies maximize their return on investment
Rationale: ICH GCP provides an international ethical and scientific quality
standard for designing, conducting, recording, and reporting trials involving human
subjects. Its primary purpose is to provide assurance that data and reported
results are credible and accurate, and that the rights, safety, and well-being of
trial subjects are protected. This fundamental principle remains unchanged in
E6(R3).
Question 2
A clinical research coordinator discovers that a subject missed two study visits.
What is this considered?
A) Adverse event
B) Protocol deviation
C) Serious noncompliance
D) Data discrepancy
Rationale: A missed scheduled study visit is considered a protocol deviation — a
change, divergence, or departure from the IRB-approved protocol. All protocol
,deviations should be documented, reported to the IRB per site policy, and
discussed with the Principal Investigator.
Question 3
What is the timeframe for submitting an IND Safety Report to the FDA for a fatal
or life-threatening unexpected suspected adverse reaction?
A) 24 hours
B) 7 calendar days
C) 15 calendar days
D) 30 calendar days
Rationale: Under 21 CFR 312.32, IND Safety Reports for fatal or life-
threatening unexpected suspected adverse reactions must be submitted to the
FDA within 7 calendar days. Other serious unexpected suspected adverse
reactions must be submitted within 15 calendar days. This timeframe is consistent
across clinical research regulations.
Question 4
Which of the following is an example of source documentation in a clinical trial?
A) The Case Report Form (CRF)
B) The subject's original medical record
C) The statistical analysis plan
D) The study protocol
Rationale: Source documentation consists of original records and certified copies
of clinical findings, observations, or other activities. Source documents
include medical records, laboratory reports, participant diaries, and other original
records where data are first recorded. The CRF is where data from source
documents are transcribed, not the source itself.
Question 5
What is the investigator's responsibility regarding investigational product
accountability?
,A) To ensure that the product is stored in the investigator's office
B) To maintain accurate records of the receipt, dispensing, and return of the
investigational product
C) To allow anyone to dispense the product without documentation
D) To destroy unused product without any recordkeeping
Rationale: The investigator is responsible for maintaining accurate records of
the receipt, dispensing, and return of the investigational product. This ensures
accountability and allows reconciliation of the product at the end of the study.
Question 6
What is the purpose of monitoring in a clinical trial?
A) To ensure the sponsor is making a profit
B) To verify that the rights and well-being of human subjects are protected,
that the reported data are accurate and complete, and that the conduct of the
trial is in compliance with the protocol, GCP, and applicable regulations
C) To ensure that the study is completed on time
D) To check the investigator's credentials only
Rationale: The purpose of monitoring is to verify that the rights and well-being of
human subjects are protected, that the reported data are accurate and complete, and
that the conduct of the trial is in compliance with the protocol, GCP, and
applicable regulations. Monitoring is a critical GCP requirement.
Question 7
What is the purpose of a Case Report Form (CRF)?
A) To record adverse events only
B) To collect and record data for each trial participant in a standardized
format
C) To obtain informed consent
D) To document the study protocol only
Rationale: A Case Report Form (CRF) is a document used to collect and record
data for each trial participant in a standardized format. It ensures that data are
collected consistently across all sites and participants, enabling accurate analysis.
, Question 8
What is the difference between a protocol deviation and a protocol violation?
A) There is no difference; they are the same
B) A protocol deviation is a minor departure from the protocol; a protocol
violation is a significant departure that may affect participant safety or data
integrity
C) A protocol deviation is intentional; a protocol violation is unintentional
D) A protocol deviation is reported to the FDA; a protocol violation is not
Rationale: A protocol deviation is generally a minor departure from the protocol
that does not significantly affect participant safety or data integrity. A protocol
violation is a significant departure that may affect participant safety, rights, or
welfare, or the integrity of the study data. Violations require more urgent reporting
and corrective action.
Question 9
What is the purpose of a query in clinical data management?
A) To ask the participant a question about their health
B) To request clarification or correction of data that appears to be missing,
inconsistent, or erroneous
C) To change the protocol mid-study
D) To terminate a participant from the study
Rationale: A query is a request for clarification or correction of data that appears
to be missing, inconsistent, or erroneous. Queries are typically generated by data
management or monitors and must be resolved before the database is locked.
Question 10
What is the purpose of the Investigator's Brochure (IB)?
A) A document that lists all study personnel
B) A comprehensive document containing the clinical and non-clinical data on
the investigational product
